EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy

Xing-Xing Shi, Zhi-Zheng Wang, Fan Wang, Ge-Fei Hao iD, Guang-Fu Yang iD

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Xing-Xing Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Green Pesticide, Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, Central China Normal University, W…. Hauptthemen laut MEDLINE: Drug Discovery, Data Visualization, Computer Simulation, Drug Evaluation, Preclinical. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug discovery, which plays a vital role in maintaining human health, is a persistent challenge. Fragment-based drug discovery (FBDD) is one of the strategies for the discovery of novel candidate compounds. Computational tools in FBDD could help to identify potential drug leads in a cost-efficient and time-saving manner. The Auto Core Fragment in silico Screening (ACFIS) server is a well-established and effective online tool for FBDD. However, the accurate prediction of protein-fragment binding mode and affinity is still a major challenge for FBDD due to weak binding affinity. Here, we present an updated version (ACFIS 2.0), that incorporates a dynamic fragment growing strategy to consider protein flexibility. The major improvements of ACFIS 2.0 include (i) increased accuracy of hit compound identification (from 75.4% to 88.5% using the same test set), (ii) improved rationality of the protein-fragment binding mode, (iii) increased structural diversity due to expanded fragment libraries and (iv) inclusion of more comprehensive functionality for predicting molecular properties. Three successful cases of drug lead discovery using ACFIS 2.0 are described, including drugs leads to treat Parkinson's disease, cancer, and major depressive disorder. These cases demonstrate the utility of this web-based server. ACFIS 2.0 is freely available at http://chemyang.ccnu.edu.cn/ccb/server/ACFIS2/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryData VisualizationComputer SimulationDrug Evaluation, PreclinicalHumansMajor Depressive DisorderProteinsNeoplasmsParkinson DiseaseInternet

Substanzen

Proteins

Autor:innen und Institutionen

  • National Key Laboratory of Green Pesticide, Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, Central China Normal University, Wuhan430079, P.R. China.

ORCID-Profile: Ge-Fei Hao, Guang-Fu Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shi, X. X., Wang, Z. Z., Wang, F., Hao, G. F., & Yang, G. F. (2023). ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad348

Vancouver

Shi XX, Wang ZZ, Wang F, Hao GF, Yang GF. ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad348

BibTeX
@article{Shi2023,
  author = {Shi, Xing-Xing and Wang, Zhi-Zheng and Wang, Fan and Hao, Ge-Fei and Yang, Guang-Fu},
  title = {ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad348}
}
Kostenlos starten →